CoChat

YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner

Open access

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

RNA-binding proteins (RBPs) are critical regulators of transcription and translation that are often dysregulated in cancer. Although RBPs are increasingly recognized as being important for normal hematopoiesis and for hematologic malignancies as oncogenes or tumor suppressors, RBPs that are essential for the maintenance and survival of leukemia remain elusive. Here we show that YBX1 is specifically required for maintaining myeloid leukemia cell survival in an N6-methyladenosine (m6A)-dependent manner. We found that expression of YBX1 is significantly upregulated in myeloid leukemia cells, and deletion of YBX1 dramatically induces apoptosis and promotes differentiation coupled with reduced proliferation and impaired leukemic capacity of primary human and mouse acute myeloid leukemia cells in vitro and in vivo. Loss of YBX1 has no obvious effect on normal hematopoiesis. Mechanistically, YBX1 interacts with insulin-like growth factor 2 messenger RNA (mRNA)-binding proteins (IGF2BPs) and stabilizes m6A-tagged RNA. Moreover, YBX1 deficiency dysregulates the expression of apoptosis-related genes and promotes mRNA decay of MYC and BCL2 in an m6A-dependent manner, which contributes to the defective survival that results from deletion of YBX1. Thus, our findings have uncovered a selective and critical role of YBX1 in maintaining myeloid leukemia survival, which might provide a rationale for the therapeutic targeting of YBX1 in myeloid leukemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood.2020009676

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 217

Metadata

Authors
Feng, M., Xie, X., Han, G., Zhang, T., Li, Y., Li, Y., Yin, R., Wang, Q., Zhang, T., Wang, P., Hu, J., Cheng, Y., Gao, Z., Wang, J., Chang, J., Cui, M., Gao, K., Chai, J., Liu, W., Guo, C., Li, S., Liu, L., Zhou, F., Chen, J., & Zhang, H.
Affiliations
  • Wuhan University (CN)
  • The State Key Laboratory Breeding Base of Basic Science of Stomatology–Key Laboratory of Oral Biomedicine, Ministry of Education, School and Hospital of Stomatology, and
  • University of Massachusetts Chan Medical School (US)
  • Wuhan Union Hospital (CN)
  • City of Hope (US)
Venue
Blood
Published
2021-03-24
Volume
138
Issue
1
Pages
71-85
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W3137919635
Cited by
213
References
52
Citations by year
2026: 28 · 2025: 55 · 2024: 48 · 2023: 34 · 2022: 37 · 2021: 11
FWCI
10.52
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship@UMassChan (submittedVersion)
Funders
  • National Natural Science Foundation of China (81500133, 81722003, 81870124)
  • Natural Science Foundation of Hubei Province (81500133, 2018CFA018, 2019CFA073)
  • Wuhan University (TFJC2018005)
  • National Key Research and Development Program of China (2017YFA0505600)
  • Wuhan Science and Technology Project
  • National Cancer Institute (R01CA214965, R01CA243386, R01CA236399, R01CA245147, R01CA222590, R01CA211614)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124116, R56DK120282)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Keywords
YB-1, myeloid leukemia, leukemia cell survival, N6-methyladenosine, RNA methylation, IGF2BP, RNA-binding proteins, mRNA stability, c-Myc, apoptosis, differentiation, therapeutic target
MeSH terms
Adenosine, Animals, Cell Survival, Hematopoiesis, Humans, Mice, Inbred C57BL, RNA, Neoplasm, Leukemia, Myeloid, Acute, Gene Expression Regulation, Leukemic, Proto-Oncogene Proteins c-myc, RNA-Binding Proteins, Apoptosis, Gene Deletion, Proto-Oncogene Proteins c-bcl-2, Mice, Y-Box-Binding Protein 1, Protein Stability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner. https://app.cochat.ai/papers/10.1182/blood.2020009676
The paper
Feng, M., Xie, X., Han, G., Zhang, T., Li, Y., Li, Y., Yin, R., Wang, Q., Zhang, T., Wang, P., Hu, J., Cheng, Y., Gao, Z., Wang, J., Chang, J., Cui, M., Gao, K., Chai, J., Liu, W., . . . Zhang, H. (2021). YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner. Blood. https://doi.org/10.1182/blood.2020009676

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.